If you are evaluating commercialization strategy for a diagnostic platform, preparing for U.S. market entry, or assessing adoption risk prior to a major milestone, we welcome an introductory discussion.
30 minute diagnostic conversation to identify the most critical commercialization risk in your current plan.
Preparing a diagnostic platform for U.S. market entry. Aligning clinical evidence with reimbursement strategy. Evaluating commercialization readiness prior to regulatory submission. Designing distribution or channel strategy. Assessing adoption risk before fundraising or launch.
Email: info@advisorydx.com. Phone: (561) 896-9090.
AdvisoryDx LLC, 7901 4th St N, Suite 300, St. Petersburg, FL 33702.